The intrinsic coagulation activity assay

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 5, 2006, Pages 369-378

  Stief, Thomas W ^a,b   Otto, Stefanie ^a   Renz, Harald ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Activated partial thromboplastin time; Hemostasis; Intrinsic coagulation activity assay; Thrombin

Indexed keywords

ARGININE; CALCIUM CHLORIDE; CHROMOGENIC SUBSTRATE; FIBRIN; SILICON DIOXIDE; THROMBIN;

ARTICLE; BLOOD CLOTTING; BLOOD STORAGE; CONTROLLED STUDY; COOLING; FREEZING; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; KINETICS; LYOPHILISATE; PARTIAL THROMBOPLASTIN TIME; PARTICLE SIZE; PLASMA; PRIORITY JOURNAL; ROOM TEMPERATURE; THAWING; THROMBOCYTE;

BLOOD COAGULATION TESTS; CHROMOGENIC COMPOUNDS; COLD; COLD TEMPERATURE; HUMANS; NEPHELOMETRY AND TURBIDIMETRY; PLASMA; REFERENCE VALUES; THROMBIN;

EID: 33745356348     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000233367.95733.d8     Document Type: Article

References (14)

1. Horne MK. Hemostatic testing and laboratory interpretation. In: Kitchens CS, Alving BM, Kessler CM, editors. Consultative hemostasis and thrombosis. Philadelphia, PA: W.B. Saunders Company; 2002. pp. 15-26.
2. Kitchens CS. The contact system. Arch Pathol Lab Med 2002; 126:1382-1386.
3. Colman RW, Schmaier AH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997; 90:3819-3843.
4. Tapper H, Herwald H. Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood 2000; 96:2329-2337.
5. Corti R, Badimon JJ. Biologic aspects of vulnerable plaque. Curr Opin Cardiol 2002; 17:616-625.
6. Khrenov AV, Ananyeva NM, Griffin JH, Saenko EL. Coagulation pathways in atherothrombosis. Trends Cardiovasc Med 2002; 12:317-324.
7. Ananyeva NM, Kouiavskaia DV, Shima M, Saenko EL. Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque. Blood 2002; 99:4475-4485.
8. Langdell RD, Wagner RH, Brinkhous KM. Effect of antihemophilic factor on one-stage clotting tests: a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure. J Lab Clin Med 1953; 41:637-647.
9. Chandler WL, Rodgers GM, Sprouse JT, Thompson AR. Elevated hemostatic factor levels as potential risk factors for thrombosis. Arch Pathol Lab Med 2002; 126:1405-1414.
10. Stief TW. Specific determination of plasmatic thrombin. Clin Appl Thromb/Hemost 2006; in press.
11. Stief TW, Weippert M, Kretschmer V, Renz H. Arginine inhibits hemostasis activation. Thromb Res 2001; 104:265-274.
12. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33:4-15.
13. Gallimore MJ, Friberger P. Chromogenic peptide substrate assays and their clinical applications. Blood Rev 1991; 5:117-127.
14. Stief TW. Kallikrein activates prothrombin. Clin Appl Thromb/Hemost 2006; in press.